



| Name Lynn Wimett, EdD |
|
| Title Professor, Nursing |
|
| Phone 303 458 4063 800-388-2366 x5131 Fax: 303-964-5325 |
|
| Location 218 Carroll Hall |
|
| e-mail lwimett@regis.edu |
|
|
|
|
|
|
|
Wimett, L. & Laustsen, G. (2004). Ketek: Telithromycin. The Nurse Practitioner: The American Journal of Primary Health Care, 29(9) 56-60. Wimett, L. & Laustsen, G. (2004). Inspra improves survival for CHF patients. The Nurse Practitioner: The American Journal of Primary Health Care, 29(7), 56-59. Laustsen, G. & Wimett, L. (2004). Drug news: Caduet treats two cardiovascular conditions at once. The Nurse Practitioner: The American Journal of Primary Health Care, 29(6), 56-57. Leonard, K., Laustsen, G. & Wimett, L. (2004). Treatment and prevention of dyslipidemia with rosuvastatin (Crestor). The Nurse Practitioner: The American Journal of Primary Health Care, 29(5), 11-15. Laustsen, G. & Wimett, L. (2004). Drug approval highlights for 2003. The Nurse Practitioner: The American Journal of Primary Health Care, 29(2), 8-21. Laustsen, G. & Wimett, L. (2005). FDA Update: 2004 Drug Approval Highlights. The Nurse Practitioner: The American Journal of Primary Health Care, 30(2), 14-29. Laustsen, G. & Gilber, M. & Wimett, L. (2006). A look bak at the most influential drug approvals of 05. The Nurse Practitioner: The American Journal of Primary Health Care, 31(2), 26-36. | |
|
|
|
|
|
|